3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
14
Peritoneal Neoplasms
10
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
5
Colorectal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Neoplasm Metastasis
3
Appendiceal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastric Adenocarcinoma
2
Carcinoma
2
Wilms Tumor
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Peritoneal Diseases
1
Malignant Neoplasm of Colorectum
1
Gastrointestinal Neoplasms
1
Gastric Cancer Peritoneal Metastases
1
Exploratory Behavior
1
Drug-Related Side Effects and Adverse Reactions
1
Desmoplastic Small Round Cell Tumor
1
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
Cyclophosphamide
58
Dexamethasone
50
Rituximab
39
Peripheral Blood Stem Cell Transplantation
29
Paclitaxel
29
Lenalidomide
28
fludarabine phosphate
27
Gemcitabine
26
Etoposide
26
Bortezomib
26
Cytarabine
25
Busulfan
24
pembrolizumab
21
Radiotherapy
21
Bevacizumab
21
Carboplatin
20
Mycophenolic Acid
19
Melphalan
19
Cisplatin
19
Filgrastim
18
pomalidomide
17
fludarabine
17
Oxaliplatin
17
Antilymphocyte Serum
17
Cyclosporine
16
Tacrolimus
15
Methotrexate
15
Whole-Body Irradiation
14
Methylprednisolone
13
Bendamustine Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Recurrence
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT01588964
2012-05-01
IPHC
Catholic University of the Sacred Heart
Phase 2
Completed
30 enrolled